Kronox Lab Sciences Ltd
Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health;… Read more
Kronox Lab Sciences Ltd (KRONOX) - Total Assets
Latest total assets as of September 2025: ₹1.13 Billion INR
Based on the latest financial reports, Kronox Lab Sciences Ltd (KRONOX) holds total assets worth ₹1.13 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Kronox Lab Sciences Ltd - Total Assets Trend (2022–2025)
This chart illustrates how Kronox Lab Sciences Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Kronox Lab Sciences Ltd - Asset Composition Analysis
Current Asset Composition (March 2025)
Kronox Lab Sciences Ltd's total assets of ₹1.13 Billion consist of 64.1% current assets and 35.9% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 3.1% |
| Accounts Receivable | ₹203.58 Million | 20.6% |
| Inventory | ₹63.72 Million | 6.5% |
| Property, Plant & Equipment | ₹0.00 | 0.0% |
| Intangible Assets | ₹0.00 | 0.0% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2022–2025)
This chart illustrates how Kronox Lab Sciences Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kronox Lab Sciences Ltd's current assets represent 64.1% of total assets in 2025, a decrease from 77.8% in 2022.
- Cash Position: Cash and equivalents constituted 3.1% of total assets in 2025, up from 0.5% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
- Asset Diversification: The largest asset category is accounts receivable at 20.6% of total assets.
Kronox Lab Sciences Ltd Competitors by Total Assets
Key competitors of Kronox Lab Sciences Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Chinyang Hold
KO:100250
|
Korea | ₩686.19 Billion |
|
DL Holdings Co Ltd Preferred
KO:000215
|
Korea | ₩12.05 Trillion |
|
Norooholdings
KO:000320
|
Korea | ₩1.26 Trillion |
|
Noroo Holdings Co Ltd
KO:000325
|
Korea | ₩1.26 Trillion |
|
Samhwa Paint
KO:000390
|
Korea | ₩617.09 Billion |
|
Chongqing Sanxia Paints Co Ltd
SHE:000565
|
China | CN¥1.65 Billion |
|
Hengyi Petrochemical Co Ltd
SHE:000703
|
China | CN¥111.51 Billion |
|
Guangdong Xinhui Meida Nylon Co Ltd
SHE:000782
|
China | CN¥3.04 Billion |
Kronox Lab Sciences Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Kronox Lab Sciences Ltd generates 1.01x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Kronox Lab Sciences Ltd generates $ 25.77 in net profit.
Kronox Lab Sciences Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.17 | 6.19 | 6.07 |
| Quick Ratio | 7.41 | 5.12 | 4.87 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₹711.34 Million | ₹ 414.90 Million | ₹ 389.26 Million |
Kronox Lab Sciences Ltd - Advanced Valuation Insights
This section examines the relationship between Kronox Lab Sciences Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.11 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 33.6% |
| Total Assets | ₹988.26 Million |
| Market Capitalization | $12.30 Million USD |
Valuation Analysis
Below Book Valuation: The market values Kronox Lab Sciences Ltd's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Kronox Lab Sciences Ltd's assets grew by 33.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Kronox Lab Sciences Ltd (2022–2025)
The table below shows the annual total assets of Kronox Lab Sciences Ltd from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹988.26 Million | +33.56% |
| 2024-03-31 | ₹739.94 Million | +36.94% |
| 2023-03-31 | ₹540.34 Million | -4.85% |
| 2022-03-31 | ₹567.88 Million | -- |